Retatrutide
Triple Receptor Agonist
Retatrutide (LY-3437943) is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This investigational compound represents a new class of multi-receptor agonist peptides being studied for metabolic research applications.
Key Features:
- High purity (≥ 99.6%)
- White lyophilized powder
- Triple receptor activity (GIP/GLP-1/Glucagon)
- Novel research compound
Research Applications:
- Metabolic regulation studies
- Receptor binding and activation research
- Energy homeostasis studies
- Incretin pathway research
Customer Reviews
Outstanding quality for our obesity research applications. The triple receptor agonist properties are well-preserved in this formulation.
Good product for GLP-1 research. Arrived well-packaged and the COA documentation is comprehensive. Looking forward to ordering more.
High purity Retatrutide. Our metabolic research team is impressed with the quality. The tri-agonist peptide is well-synthesized and stable.
Excellent Retatrutide for our triple agonist research. The GLP-1/GIP/glucagon receptor binding studies show clean results with this product.
Sign in to leave a review.
